Bookmark?Remove?
Germany’s Merck in fresh bid to enter U.S. MS pill market
The logo of German pharmaceuticals company Merck is seen in front of the company’s headquarters in Darmstadt, Germany, May 16, 2016. REUTERS/Kai Pfaffenbach FRANKFURT (Reuters) – Germany’s Merck KGaA (MRCG.DE) is reviving plans to bring an oral multiple sclero... More »
